Original Research

Published on 06 Aug 2024

Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer

in Cancer Immunity and Immunotherapy

Yirong Li
Yue Cui
Zhen Wang
Liwei Wang
Yi Yu
Yuyan Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419133

1,976 views

Correction

Published on 05 Aug 2024

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

in Cancer Immunity and Immunotherapy

Longsha Liu
Thijs A. van Schaik
Kok-Siong Chen
Filippo Rossignoli
Paulo Borges
Vladimir Vrbanac
Hiroaki Wakimoto
Khalid Shah

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466387

571 views

Review

Published on 05 Aug 2024

TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression

in Cancer Immunity and Immunotherapy

Banglu Wang
Fan Zhang
Xiaoyu Wu
Mei Ji

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433321

1,345 views
1 citation

Review

Published on 05 Aug 2024

The current status and future of targeted-immune combination for hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Liyuan Hao
Shenghao Li
Fanghang Ye
Hengyi Wang
Yuxin Zhong
Xiaoyi Zhang
Xiaoyu Hu
Xiaopeng Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418965

2,374 views

Original Research

Published on 05 Aug 2024

Exercise-augmented THSD7B exhibited a positive prognostic implication and tumor-suppressed functionality in pan-cancer

in Cancer Immunity and Immunotherapy

Zhiwen Luo
Jinguo Zhu
Zhengyuan Fang
Rui Xu
Renwen Wan
Yanwei He
Yisheng Chen
Shuo Chen
Qing Wang
Qizhi Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440226

1,738 views
1 citation

Mini Review

Published on 05 Aug 2024

Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance

in Cancer Immunity and Immunotherapy

Xiaolin Wu
Nuan Feng
Chao Wang
Hongfei Jiang
Zhu Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444452

1,157 views
2 citations

Original Research

Published on 05 Aug 2024

Plasma extracellular vesicle long RNA profiling identifies a predictive signature for immunochemotherapy efficacy in lung squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Xin Zhang
Jiatao Liao
Wenyue Yang
Qiaojuan Li
Zhen Wang
Hui Yu
Xianghua Wu
Huijie Wang
Si Sun
Xinmin Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421604

1,260 views

Original Research

Published on 05 Aug 2024

Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours

in Cancer Immunity and Immunotherapy

Patrick Freeman
Gaia Bellomo
Lucy Ireland
Maidinaimu Abudula
Teifion Luckett
Michael Oberst
Ruth Stafferton
Paula Ghaneh
Chris Halloran
Michael C. Schmid

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382538

1,426 views

Review

Published on 02 Aug 2024

The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy

in Cancer Immunity and Immunotherapy

Kosuke Murakami
Sudipto Ganguly

Frontiers in Immunology

doi 10.3389/fimmu.2024.1441730

2,127 views

Systematic Review

Published on 02 Aug 2024

Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Huipeng Fang
Qiao Ke
Shiji Wu
Qiang Tu
Lei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421520

1,473 views
1 citation

Original Research

Published on 02 Aug 2024

Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression

in Cancer Immunity and Immunotherapy

Yimeng Guo
Lihua Li
Keao Zheng
Juan Du
Jingxu Nie
Zanhong Wang
Zhiying Hao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1431150

1,629 views
1 citation

Original Research

Published on 01 Aug 2024

Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer

in Cancer Immunity and Immunotherapy

Łukasz Kuncman
Matusz Pajdziński
Krzysztof Smółka
Mateusz Bilski
Joanna Socha
Rafał Stando
Magdalena Peszyńska-Piorun
Katarzyna Korab
Barbara Alicja Jereczek-Fossa
Jacek Fijuth

Frontiers in Immunology

doi 10.3389/fimmu.2024.1426635

2,023 views

Original Research

Published on 01 Aug 2024

Insights into the recognition of hypermucoviscous Klebsiella pneumoniae clinical isolates by innate immune lectins of the Siglec and galectin families

in Cancer Immunity and Immunotherapy

María Asunción Campanero-Rhodes
Sara Martí
Noelia Hernández-Ortiz
Meritxell Cubero
June Ereño-Orbea
Ana Ardá
Jesús Jiménez-Barbero
Carmen Ardanuy
Dolores Solís

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436039

1,373 views

Review

Published on 01 Aug 2024

The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis

in Cancer Immunity and Immunotherapy

Evelyn Calderon-Espinosa
Kirsten De Ridder
Thomas Benoot
Yanina Jansen
Domien Vanhonacker
Robbe Heestermans
Ann De Becker
Ivan Van Riet
Lore Decoster
Cleo Goyvaerts

Frontiers in Immunology

doi 10.3389/fimmu.2024.1397469

2,153 views
1 citation

Review

Published on 01 Aug 2024

HSP90 multi-functionality in cancer

in Cancer Immunity and Immunotherapy

Zarema Albakova

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436973

2,332 views

Review

Published on 01 Aug 2024

Advances and challenges in anti-cancer vaccines for multiple myeloma

in Cancer Immunity and Immunotherapy

Pegah Abdollahi
Hanne Marie Norseth
Fredrik Schjesvold

Frontiers in Immunology

doi 10.3389/fimmu.2024.1411352

1,471 views

Navigation group

Articles

Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression

The current status and future of targeted-immune combination for hepatocellular carcinoma

Exercise-augmented THSD7B exhibited a positive prognostic implication and tumor-suppressed functionality in pan-cancer

Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance

Plasma extracellular vesicle long RNA profiling identifies a predictive signature for immunochemotherapy efficacy in lung squamous cell carcinoma

Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours

The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy

Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis

Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression

Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer

Insights into the recognition of hypermucoviscous Klebsiella pneumoniae clinical isolates by innate immune lectins of the Siglec and galectin families

The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis

HSP90 multi-functionality in cancer

Advances and challenges in anti-cancer vaccines for multiple myeloma